Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
American Journal of Cancer Research|November 9, 2016
Hydroxyl-HIF2-alpha is potential therapeutic target for renal cell carcinomasTakahiro Isono, Tokuhiro Chano, Tetsuya Yoshida, et al.
Expert Review of Anticancer Therapy|May 30, 2024
Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative reviewMartin Zarba, Ryo Fujiwara, Takeshi Yuasa, et al.
Targeted Oncology|June 1, 2020
Impact of Serum γ-Glutamyltransferase on Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted TherapyKosuke Takemura, Takeshi Yuasa, Kentaro Inamura, et al.
Japanese Journal of Cancer Research : Gann|May 31, 2002
High expression of human uroplakin Ia in urinary bladder transitional cell carcinomaSusumu Kageyama, Tatsuhiro Yoshiki, Takahiro Isono, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Switching Patients With Prostate Cancer from GnRH Antagonist to Long-acting LHRH Agonist for Androgen Deprivation: Reducing Hospital Visits During the Coronavirus PandemicMotohiro Fujiwara, Takeshi Yuasa, Yoshinobu Komai, et al.
Urology|September 2, 2018
Preliminary Kidney Parenchymal Ligation Using Endoloop Ligatures-A Simple Method to Achieve a Trifecta in Laparoscopic Partial Nephrectomy Without Hilar Clamping for Polar Complex TumorsYoshinobu Komai, Naoto Gotohda, Nobuaki Matsubara, et al.
Oncology Reports|March 10, 2005
Expression of thymidine phosphorylase correlates with microvessel density in prostate cancerAkira Kataoka, Takeshi Yuasa, Susumu Kageyama, et al.
Cancer Letters|December 25, 2004
Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo modelsMasaki Nogawa, Takeshi Yuasa, Shinya Kimura, et al.
The Annals of Thoracic Surgery|March 20, 2002
Functional recovery of the native heart after cardiomyoplasty in sheep with heart failure: passive and dynamic effects of volume loadingKazuaki Shirota, Yifei Huang, Osamu Kawaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivoTakeshi Yuasa, Masaki Nogawa, Shinya Kimura, et al.
Pageof 22